Myocardial revascularization of the beating heart in high-risk patients

G D'Ancona1, H Karamanoukian, A T Kawaguchi

  • 1State University of New York at Buffalo and Kaleida Health, Buffalo General Hospital, USA.

Insights

Off-pump coronary artery bypass grafting (CABG) is a safe alternative for high-risk patients. This approach significantly reduces perioperative complications compared to conventional CABG with cardiopulmonary bypass (CPB).

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Anesthesia

Background:

  • Coronary artery bypass grafting (CABG) using cardiopulmonary bypass (CPB) poses risks for high-risk patients.
  • Off-pump CABG (OPCAB) has emerged as a potential alternative to mitigate these risks.

Purpose of the Study:

  • To evaluate the benefits and safety of myocardial revascularization performed without CPB (OPCAB).
  • To compare perioperative outcomes of OPCAB versus conventional CABG (ONCAB) in high-risk patient subgroups.

Main Methods:

  • Retrospective analysis of OPCAB and ONCAB procedures from January 1995 to December 1999.
  • Patients categorized into high-risk groups: age >80 years, reoperative CABG, or left ventricular ejection fraction <40%.
  • Comparison of perioperative results and complications between OPCAB and ONCAB groups within these subgroups.

Main Results:

  • No significant differences in preoperative comorbidities between OPCAB and ONCAB groups.
  • More extensive coronary artery disease was noted in ONCAB patients.
  • OPCAB demonstrated a trend towards fewer perioperative complications, with significantly higher freedom from overall complications (p < 0.005).
  • Mortality rates were comparable between OPCAB and ONCAB groups (p = NS).

Conclusions:

  • Coronary artery bypass grafting can be safely performed without CPB in high-risk individuals.
  • The OPCAB technique is associated with markedly higher freedom from perioperative complications.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...